T1D Exchange, a nonprofit organization, is a dynamic, multi-purpose, real-world patient data platform designed to accelerate all aspects of drug and device development. T1D Exchange has established a unique model to speed better treatments, therapies and research for type 1 diabetes (T1D). The Exchange consists of an integrated Clinic Network of 65+ clinics across the U.S., and Glu which is an online community with mobile capabilities for people touched by type 1 diabetes. The T1D Exchange fosters faster and more fluid information transfer and sharing among diabetes patients, physicians, researchers, and pharma, medical device, education, and outreach organizations. T1D Exchange is committed to supporting personalized medicine research and improving patient outcomes through an integrated approach optimizing social media, health information technology, bioinformatics and mHealth platforms. The Exchange leverages an ecosystem comprised of life-science companies, public and private foundations, private equity, physician communities, patient communities, and government agencies. The Exchange’s mission is to improve the outcomes of people touched by type 1 diabetes by facilitating better care and accelerating new therapies on the path to a cure.